Evidence map›Paper›PMID 36891749›Full record

ArticleHaematologica2023

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

Pierre Walczak, Sylvain Choquet, Jacques Dantal, David Boutboul, Felipe Suarez, Marine Baron, Veronique Morel, Thomas Cluzeau, Mohamed Touati, Michelle Elias and 21 more

Abstract read
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Pierre WalczakSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
Sylvain ChoquetSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
Jacques DantalInstitut de Transplantation Urologie Nephrologie (ITUN), Service de Nephrologie et Immunologie clinique, CHU Nantes, Nantes.
David BoutboulService d'Immunologie Clinique, Hopital Saint-Louis, APHP, Paris.
Felipe SuarezService d'Hematologie Clinique, Hopital Necker, APHP, Paris.
Marine BaronSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
Veronique MorelSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
Thomas CluzeauService d'Hematologie Clinique, CHU de Nice, Nice.
Mohamed TouatiService d'Hematologie Clinique, CHU Limoges, Limoges.
Michelle EliasService de Nephrologie, Hopital Saint-Louis, APHP, Paris.
Emmanuel BachyService d'Hematologie Clinique, Hospices Civils de Lyon, Pierre-Benite.
Emmanuelle Nicolas-VirelizierService d'Hematologie, Centre Leon Berard, Lyon.
Roch HouotService d'hematologie, CHU Rennes, Universite de Rennes, INSERM U1236, Rennes.
Geoffroy VentonService d'Hematologie et Therapie Cellulaire, Hopital universitaire de la Conception, Marseille.
Caroline JacquetService d'Hematologie, CHU de Nancy, Vandoeuvre les Nancy.
Marie-Pierre Moles-MoreauService d'Hematologie, CHU d'Angers, Angers.
Fabrice JardinService d'Hematologie, Centre Henri Becquerel, Rouen.
Eric DurotCHU Reims, Hematologie Clinique, F-51100 Reims.
Noureddine BalegrouneSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
Laure EcotiereService de Nephrologie, Hemodialyse et Transplantation renale, Centre Hospitalier Universitaire de Poitiers, Poitiers.
Romain GuiezeService d'Hematologie Clinique et Therapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand France.
Nassim KamarService de Nephrologie et Transplantation d'Organes, CHU Rangueil, Toulouse.
Loic YsebaertService d'Hematologie, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse.
Lionel CouziService de Nephrologie, transplantation, dialyse et aphereses, CHU Bordeaux.
Hugo GonzalezService d'Hematologie, Centre Hospitalier Rene-Dubos, Pontoise.
Louise RoulinService Unite Hemopathies Lymphoides, Groupe Hospitalo-universitaire Chenevier Mondor, APHP Creteil.
Kevin OuService de Nephrologie et Transplantation Renale, Hopital Foch, Suresnes.
Sophie CaillardService de Nephrologie et Transplantation Renale, CHU de Strasbourg, Strasbourg.
Heiner ZimmermannDepartment of Internal Medicine-Oncology, Carl v. Ossietzky University of Oldenburg, Pius-Hospital, Oldenburg, Germany; Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Gropelinger Heerstr. 406-408, 28239, Bremen.
Ralf Ulrich TrappeDepartment of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Gropelinger Heerstr. 406-408, 28239, Bremen, Germany; Department of Internal Medicine II: Haematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel.
Damien Roos-WeilSorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris. damien.roosweil@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideHumansRetrospective StudiesCyclophosphamide

Identifiers

PMID36891749
PMCPMC10543171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.